{"id":"https://openalex.org/W4387709776","doi":"https://doi.org/10.1016/j.pscia.2023.100020","title":"Biowaiver based on biopharmaceutics classification system: Considerations and requirements","display_name":"Biowaiver based on biopharmaceutics classification system: Considerations and requirements","alternate_titles":[],"publication_year":2023,"publication_date":"2023-10-17","ids":{"openalex":"https://openalex.org/W4387709776","doi":"https://doi.org/10.1016/j.pscia.2023.100020","pmid":"https://pubmed.ncbi.nlm.nih.gov/41550151","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12709982"},"language":"en","primary_location":{"id":"doi:10.1016/j.pscia.2023.100020","doi":"https://doi.org/10.1016/j.pscia.2023.100020","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.pscia.2023.100020","pdf_url":null,"source":{"id":"https://openalex.org/S4387285665","display_name":"Pharmaceutical Science Advances","issn_l":"2773-2169","issn":["2773-2169"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Science Advances","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4387709776"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.pscia.2023.100020","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093077996","display_name":"Pratik R. Dhake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098333","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/011npsm46","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210098333"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Pratik R. Dhake","raw_affiliation_strings":["Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, 844 102, Bihar, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, 844 102, Bihar, India","institution_ids":["https://openalex.org/I4210098333"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084829607","display_name":"Smita Tukaram Kumbhar","orcid":"https://orcid.org/0000-0002-3030-9477","observed_orcids":["https://orcid.org/0000-0002-3030-9477"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/resources","display_name":"Resources"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Smita T. Kumbhar","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, DSTS Mandal's College of Pharmacy, Solapur- 413 004, Maharashtra, India"],"raw_orcid":"https://orcid.org/0000-0002-3030-9477","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, DSTS Mandal's College of Pharmacy, Solapur- 413 004, Maharashtra, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014313590","display_name":"Vinod Limbraj Gaikwad","orcid":"https://orcid.org/0000-0002-3368-4467","observed_orcids":["https://orcid.org/0000-0002-3368-4467"]},"institutions":[{"id":"https://openalex.org/I4210098333","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/011npsm46","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210098333"]}],"countries":["IN"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/project-administration","display_name":"Project administration"},{"id":"https://openalex.org/contributor-roles/resources","display_name":"Resources"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Vinod L. Gaikwad","raw_affiliation_strings":["Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, 844 102, Bihar, India"],"raw_orcid":"https://orcid.org/0000-0002-3368-4467","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, 844 102, Bihar, India","institution_ids":["https://openalex.org/I4210098333"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5014313590"],"corresponding_institution_ids":["https://openalex.org/I4210098333"],"apc_list":{"value":2000,"currency":"USD","value_usd":2000},"apc_paid":{"value":2000,"currency":"USD","value_usd":2000},"fwci":0.3199,"has_fulltext":true,"cited_by_count":18,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.2605985,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"2","issue":null,"first_page":"100020","last_page":"100020"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.86080002784729,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.86080002784729,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.05620000138878822,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.023000000044703484,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biowaiver","display_name":"biowaiver","score":0.9739999771118164},{"id":"https://openalex.org/keywords/biopharmaceutics-classification-system","display_name":"Biopharmaceutics Classification System","score":0.9480000138282776},{"id":"https://openalex.org/keywords/bioequivalence-studies","display_name":"bioequivalence studies","score":0.875},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.6159999966621399},{"id":"https://openalex.org/keywords/topical-drug-delivery-systems","display_name":"topical drug delivery systems","score":0.5820000171661377},{"id":"https://openalex.org/keywords/oral-films","display_name":"oral films","score":0.9639999866485596},{"id":"https://openalex.org/keywords/drug-solubility","display_name":"drug solubility","score":0.8130000233650208},{"id":"https://openalex.org/keywords/drug-permeability","display_name":"drug permeability","score":0.781000018119812},{"id":"https://openalex.org/keywords/bcs-class-ii-drugs","display_name":"BCS class II drugs","score":0.7239999771118164},{"id":"https://openalex.org/keywords/bcs-class-iv-drugs","display_name":"BCS class IV drugs","score":0.9649999737739563},{"id":"https://openalex.org/keywords/regulatory-approval","display_name":"regulatory approval","score":0.5419999957084656},{"id":"https://openalex.org/keywords/who-guidelines","display_name":"WHO guidelines","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.8713405132293701},{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.8428252935409546},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.7956733107566833},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.5023202896118164},{"id":"https://openalex.org/C2910701995","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutics","level":5,"score":0.4654453694820404},{"id":"https://openalex.org/C2778012447","wikidata":"https://www.wikidata.org/wiki/Q1034415","display_name":"Scope (computer science)","level":2,"score":0.4276289641857147},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.42116910219192505},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.38767901062965393},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34731441736221313},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3399438261985779},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3249209523200989},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.321003794670105},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.15720176696777344},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.14083319902420044},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.13282737135887146},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C160492267","wikidata":"https://www.wikidata.org/wiki/Q319616","display_name":"Pharmacognosy","level":4,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.pscia.2023.100020","doi":"https://doi.org/10.1016/j.pscia.2023.100020","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.pscia.2023.100020","pdf_url":null,"source":{"id":"https://openalex.org/S4387285665","display_name":"Pharmaceutical Science Advances","issn_l":"2773-2169","issn":["2773-2169"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Science Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12709982","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12709982/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12709982/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharm Sci Adv","raw_type":"Text"},{"id":"pmid:41550151","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41550151","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical science advances","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:e9f2ea8fcea54ad69a125770d0e823bb","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e9f2ea8fcea54ad69a125770d0e823bb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutical Science Advances, Vol 2, Iss , Pp 100020- (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.pscia.2023.100020","doi":"https://doi.org/10.1016/j.pscia.2023.100020","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.pscia.2023.100020","pdf_url":null,"source":{"id":"https://openalex.org/S4387285665","display_name":"Pharmaceutical Science Advances","issn_l":"2773-2169","issn":["2773-2169"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Science Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.4043000042438507,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387709776.pdf","grobid_xml":"https://content.openalex.org/works/W4387709776.grobid-xml"},"referenced_works_count":79,"referenced_works":["https://openalex.org/W218368498","https://openalex.org/W601386163","https://openalex.org/W653399507","https://openalex.org/W1498305210","https://openalex.org/W1501126261","https://openalex.org/W1544478883","https://openalex.org/W1971181330","https://openalex.org/W1971319971","https://openalex.org/W1976448220","https://openalex.org/W1976787897","https://openalex.org/W1978973397","https://openalex.org/W1980019774","https://openalex.org/W1982181595","https://openalex.org/W1983397539","https://openalex.org/W1988915717","https://openalex.org/W1995695108","https://openalex.org/W1997764055","https://openalex.org/W2000819024","https://openalex.org/W2006070766","https://openalex.org/W2006661934","https://openalex.org/W2015733115","https://openalex.org/W2016425824","https://openalex.org/W2017859778","https://openalex.org/W2024362305","https://openalex.org/W2038387558","https://openalex.org/W2038610991","https://openalex.org/W2038847837","https://openalex.org/W2045879423","https://openalex.org/W2047281641","https://openalex.org/W2049026746","https://openalex.org/W2060992818","https://openalex.org/W2062596549","https://openalex.org/W2063486629","https://openalex.org/W2065371215","https://openalex.org/W2069506489","https://openalex.org/W2070337781","https://openalex.org/W2071815326","https://openalex.org/W2092137244","https://openalex.org/W2101254927","https://openalex.org/W2115647292","https://openalex.org/W2116705046","https://openalex.org/W2116811376","https://openalex.org/W2124278256","https://openalex.org/W2135130257","https://openalex.org/W2151943234","https://openalex.org/W2168199456","https://openalex.org/W2181446812","https://openalex.org/W2291667458","https://openalex.org/W2293564812","https://openalex.org/W2296518610","https://openalex.org/W2392226771","https://openalex.org/W2396309968","https://openalex.org/W2481597297","https://openalex.org/W2499274410","https://openalex.org/W2566120766","https://openalex.org/W2739633564","https://openalex.org/W2746474357","https://openalex.org/W2751987943","https://openalex.org/W2766138962","https://openalex.org/W2796957864","https://openalex.org/W2811495605","https://openalex.org/W2890544003","https://openalex.org/W2955352870","https://openalex.org/W2987011511","https://openalex.org/W3046663741","https://openalex.org/W3083762401","https://openalex.org/W3083764845","https://openalex.org/W3086911025","https://openalex.org/W3133865197","https://openalex.org/W3133912430","https://openalex.org/W3200350621","https://openalex.org/W3202290265","https://openalex.org/W3209601243","https://openalex.org/W4206188931","https://openalex.org/W4213106290","https://openalex.org/W4221132321","https://openalex.org/W4285222584","https://openalex.org/W6888938243","https://openalex.org/W7162238309"],"related_works":["https://openalex.org/W3046663741","https://openalex.org/W1937861928","https://openalex.org/W4391071612","https://openalex.org/W2884064719","https://openalex.org/W7215515591","https://openalex.org/W2291667458","https://openalex.org/W2396129053","https://openalex.org/W3210648442","https://openalex.org/W7160963479","https://openalex.org/W2604564924"],"abstract_inverted_index":{"Biowaiver":[0],"allows":[1],"for":[2,8,26,57,84,135],"the":[3,24,31,42,54,95,98,121,131],"waiver":[4],"of":[5,11,17,23,97,138],"bioequivalence":[6,118],"studies":[7,28],"regulatory":[9,55,87],"approval":[10,22,137],"certain":[12],"drug":[13],"products":[14,51],"with":[15],"saving":[16],"time,":[18],"and":[19,45,60,71,77,113,133,147,151],"money.":[20],"Before":[21],"application":[25],"biowaivers,":[27],"based":[29],"on":[30,111,116],"Biopharmaceutical":[32],"Classification":[33],"System":[34],"(BCS)":[35],"are":[36,81],"required":[37],"to":[38,68,129],"satisfy":[39],"regulators":[40],"in":[41],"US,":[43],"Europe,":[44],"other":[46],"developing":[47],"markets.":[48],"Only":[49],"pharmaceutical":[50],"that":[52],"meet":[53],"requirements":[56],"solubility,":[58],"diffusion,":[59],"permeability":[61],"will":[62],"be":[63],"granted":[64],"a":[65,139,142],"biowaiver.":[66],"Due":[67],"high":[69],"solubility":[70],"considerable":[72],"permeability,":[73],"BCS":[74,104,148],"class":[75,78,149],"I":[76],"III":[79],"drugs":[80],"highly":[82],"preferred":[83],"biowaiver":[85,99,136],"by":[86,101],"agencies.":[88],"The":[89],"World":[90],"Health":[91],"Organization":[92],"recently":[93],"expanded":[94],"scope":[96],"acceptance":[100],"considering":[102],"all":[103],"classes.":[105],"These":[106],"techniques":[107],"can":[108],"cut":[109],"down":[110],"time":[112],"money":[114],"spent":[115],"ineffective":[117],"studies.":[119],"In":[120],"present":[122],"article,":[123],"an":[124],"attempt":[125],"has":[126],"been":[127],"made":[128],"cover":[130],"prerequisites":[132],"guidelines":[134],"generic":[140],"product,":[141],"topical":[143],"system,":[144],"oral":[145],"films,":[146],"II":[150],"IV":[152],"drugs.":[153]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4387709776","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2023-10-18T00:00:00"}
